AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33479274 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics administered in the first 48 hours after birth
Number of subjects: 91
Study 35055842 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based behavior change intervention
Number of subjects: 20
Study 32014355 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer benchmarking intervention tool
Number of subjects: 13
Study 32006180 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in an online support group via a closed Facebook group.
Number of subjects: 90
Study 32006180 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement in discussions on disease experiences, medications, social lives, online resources on RA, frustrations, messages of encouragement, and satirical depictions of their disease experience.
Number of subjects: 90
Study 35294706 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing Authority A vouchers
Number of subjects: 0
Study 35294706 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing Authority B vouchers
Number of subjects: 0
Study 33098483 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Choices intervention
Number of subjects: 183
Study 32216471 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 1592
Study 32216471 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 1592
Study 35567778 — intervention group
Group type: EXPERIMENTAL
Intervention: Early autologous hematopoietic cell transplantation (AHCT) with post‐transplant maintenance therapy
Number of subjects: 758
Study 35567778 — intervention group
Group type: EXPERIMENTAL
Intervention: Early autologous hematopoietic cell transplantation (AHCT)
Number of subjects: 758
Study 35567778 — intervention group
Group type: COMPARATOR
Intervention: Low symptom burden at baseline
Number of subjects: 758
Study 35567778 — intervention group
Group type: COMPARATOR
Intervention: Older age
Number of subjects: 758
Study 35567778 — intervention group
Group type: COMPARATOR
Intervention: Employment status
Number of subjects: 758
Study 34390604 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched RS2 cookies (16 g d-1 of Hi-Maize 260, Ingredion) for 4 weeks
Number of subjects: 0
Study 34390604 — intervention group
Group type: COMPARATOR
Intervention: Placebo cookies made with manioc flour
Number of subjects: 0
Study 32614262 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (n=30)
Number of subjects: 79
Study 32614262 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (n=49)
Number of subjects: 79
Study 32614262 — intervention group
Group type: COMPARATOR
Intervention: Healthy group (n=57)
Number of subjects: 79
Study 36259883 — intervention group
Group type: EXPERIMENTAL
Intervention: ARM-SAD
Number of subjects: 130
Study 36259883 — intervention group
Group type: COMPARATOR
Intervention: Standard AD
Number of subjects: 130
Study 34178124 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg intramuscular neridronate given once daily for 16 consecutive days
Number of subjects: 78
Study 34178124 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 78
Study 32728536 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Modification with calorie deficit diet and strength training
Number of subjects: 40
Study 32728536 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle Modification
Number of subjects: 40
Study 36269974 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized mirror circuits for benchmarking
Number of subjects: 16
Study 36269974 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized mirror circuits
Number of subjects: 16
Study 34541720 — intervention group
Group type: EXPERIMENTAL
Intervention: nano-curcumin
Number of subjects: 40
Study 34541720 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 36054285 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized allogeneic bone block (CABB)
Number of subjects: 24
Study 36054285 — intervention group
Group type: COMPARATOR
Intervention: Autogenous bone block (ABB)
Number of subjects: 24
Study 33016193 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced crystalloids
Number of subjects: 15802
Study 33016193 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 15802
Study 35192659 — intervention group
Group type: EXPERIMENTAL
Intervention: Video mode
Number of subjects: 154
Study 35192659 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio mode
Number of subjects: 154
Study 35192659 — intervention group
Group type: EXPERIMENTAL
Intervention: Email mode
Number of subjects: 154
Study 35192659 — intervention group
Group type: EXPERIMENTAL
Intervention: Instant chat mode
Number of subjects: 154
Study 35192659 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey mode
Number of subjects: 154
Study 35192659 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison across modes
Number of subjects: 154
Study 33246494 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT), 30–40 treatment sessions in a high pressure chamber (2.4 atmospheres absolute) inhaling 100% oxygen through a mask.
Number of subjects: 120
Study 33246494 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 120
Study 35279355 — intervention group
Group type: EXPERIMENTAL
Intervention: Homemade gelatin model
Number of subjects: 0
Study 35279355 — intervention group
Group type: COMPARATOR
Intervention: Homemade tofu model
Number of subjects: 0
Study 35279355 — intervention group
Group type: COMPARATOR
Intervention: Commercial model (US training block model)
Number of subjects: 0
Study 35279355 — intervention group
Group type: COMPARATOR
Intervention: Human tissue
Number of subjects: 0
Study 32043986 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (20 mg IV once daily from day 1 to day 5, then 10 mg IV once daily from day 6 to day 10)
Number of subjects: 277
Study 32043986 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued routine intensive care)
Number of subjects: 277
Study 36262517 — intervention group
Group type: EXPERIMENTAL
Intervention: TC-325
Number of subjects: 59
Study 36262517 — intervention group
Group type: COMPARATOR
Intervention: Control (best clinical management)
Number of subjects: 59
Study 33971353 — intervention group
Group type: EXPERIMENTAL
Intervention: Brolucizumab (3 or 6 mg)
Number of subjects: 49
Study 33971353 — intervention group
Group type: EXPERIMENTAL
Intervention: Brolucizumab therapy continued after first IOI-related AE
Number of subjects: 49
Study 33971353 — intervention group
Group type: EXPERIMENTAL
Intervention: Brolucizumab therapy not continued after first IOI-related AE
Number of subjects: 49
Study 33971353 — intervention group
Group type: EXPERIMENTAL
Intervention: Brolucizumab injections before first IOI-related AE
Number of subjects: 49
Study 33971353 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to first IOI-related AE
Number of subjects: 49
Study 33971353 — intervention group
Group type: EXPERIMENTAL
Intervention: Best-corrected visual acuity (BCVA) change
Number of subjects: 49
Study 32408979 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 1434
Study 35031632 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon extracranial venoplasty
Number of subjects: 0
Study 35031632 — intervention group
Group type: COMPARATOR
Intervention: Sham extracranial venoplasty
Number of subjects: 0
Study 34151855 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-guided DBS-settings
Number of subjects: 23
Study 34151855 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care DBS-settings
Number of subjects: 23
Study 34151855 — intervention group
Group type: EXPERIMENTAL
Intervention: Latest version of algorithm-guided DBS-settings
Number of subjects: 23
Study 32697879 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 32
Study 32697879 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 32
Study 33144085 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF)
Number of subjects: 850
Study 33144085 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive supraventricular ectopic activity (ESVEA)
Number of subjects: 850
Study 33144085 — intervention group
Group type: COMPARATOR
Intervention: Implantable cardioverter defibrillator (ICD) implantation
Number of subjects: 850
Study 35325834 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet (22% CP)
Number of subjects: 9
Study 35325834 — intervention group
Group type: EXPERIMENTAL
Intervention: Low crude fiber diet (30 g/kg CF)
Number of subjects: 9
Study 35325834 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing crude fiber levels (from 3% to 7%)
Number of subjects: 9
Study 35325834 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet of 18% CP paired with 5% CF
Number of subjects: 9
Study 34484379 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of hydrocortisone (50 mg/6 h, intravenously), Vitamin C (1.5 g/6 h in 100 ml normal saline or DW5%, intravenously), and thiamine (200 mg/12 h in 50 ml normal saline or DW5%, intravenously)
Number of subjects: 58
Study 34484379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 34484379 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of hydrocortisone, thiamine, and Vitamin C
Number of subjects: 58
Study 33303119 — intervention group
Group type: EXPERIMENTAL
Intervention: TMVr plus guideline-directed medical therapy (GDMT)
Number of subjects: 614
Study 33303119 — intervention group
Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 614
Study 36335573 — intervention group
Group type: EXPERIMENTAL
Intervention: benzoate 1000 (500 mg/day for the first 4 weeks, 1000 mg/day from the 5th week)
Number of subjects: 149
Study 36335573 — intervention group
Group type: EXPERIMENTAL
Intervention: benzoate 500 (fixed 500 mg/day)
Number of subjects: 149
Study 36335573 — intervention group
Group type: EXPERIMENTAL
Intervention: benzoate 750 (500 mg/day for the first 4 weeks, 750 mg/day from the 5th week)
Number of subjects: 149
Study 36335573 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 149
Study 35320441 — intervention group
Group type: EXPERIMENTAL
Intervention: Invention and problem-solve learning (PS-I)
Number of subjects: 0
Study 35320441 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastery Learning (ML)
Number of subjects: 0
Study 35320441 — intervention group
Group type: COMPARATOR
Intervention: Instruction then practice (CON)
Number of subjects: 0
Study 32556619 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific titanium onlay implant
Number of subjects: 10
Study 32556619 — intervention group
Group type: COMPARATOR
Intervention: Autogenous inlay grafting technique
Number of subjects: 10
Study 35870944 — intervention group
Group type: EXPERIMENTAL
Intervention: group-based parenting intervention for mothers with BPD
Number of subjects: 178
Study 35870944 — intervention group
Group type: COMPARATOR
Intervention: waiting control group
Number of subjects: 178
Study 33771557 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 pass, 3 actuations (1:3)
Number of subjects: 40
Study 33771557 — intervention group
Group type: COMPARATOR
Intervention: 1 pass, 1 actuation (1:1)
Number of subjects: 40
Study 32286322 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbowhite (siliceous enterosorbent)
Number of subjects: 144
Study 32286322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 34760143 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum as psychological intervention
Number of subjects: 89
Study 34760143 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 89
Study 33308812 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 34
Study 33308812 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 34
Study 33308812 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 34
Study 34903325 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCORd intervention (structured training for GPs on LARC counselling and access to rapid referral to insertion clinics)
Number of subjects: 0
Study 34903325 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCORd intervention
Number of subjects: 0
Study 34903325 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCORd intervention without start-up cost
Number of subjects: 0
Study 34903325 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study 32658498 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailouts plus telephone support
Number of subjects: 588
Study 32658498 — intervention group
Group type: COMPARATOR
Intervention: Mailouts alone
Number of subjects: 588
Study 32658498 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 588
Study 36091513 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Weight Clinic PWMI
Number of subjects: 26
Study 36091513 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-Healthy Weight and Your Child PWMI
Number of subjects: 26
Study 36091513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of PWMI
Number of subjects: 26
Study 32317617 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with Reduced Calcineurin Inhibitor Exposure
Number of subjects: 0
Study 32317617 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34751177 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided percutaneous Achilles tenotomy (PAT)
Number of subjects: 50
Study 34751177 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Achilles tenotomy (PAT) without image guidance
Number of subjects: 50
Study 34751177 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ultrasound-guided and control)
Number of subjects: 50
Study 33600928 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloons (DCBs)
Number of subjects: 200
Study 33600928 — intervention group
Group type: COMPARATOR
Intervention: Uncoated balloon (UCB)
Number of subjects: 200
Study 35128871 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep embedding group
Number of subjects: 92
Study 35128871 — intervention group
Group type: EXPERIMENTAL
Intervention: Shallow embedding group
Number of subjects: 92
Study 35128871 — intervention group
Group type: COMPARATOR
Intervention: Sham-embedding group
Number of subjects: 92
Study 32271055 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassionate mind training (CMT)
Number of subjects: 73
Study 32271055 — intervention group
Group type: COMPARATOR
Intervention: Relaxation music
Number of subjects: 73
Study 34971525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg i.v. infusion over 40 min)
Number of subjects: 57
Study 34971525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (10 mg/kg i.p.)
Number of subjects: 57
Study 34971525 — intervention group
Group type: EXPERIMENTAL
Intervention: (2R,6R)‐HNK (10 mg/kg i.p.)
Number of subjects: 57
Study 34971525 — intervention group
Group type: COMPARATOR
Intervention: Orchidectomy
Number of subjects: 57
Study 34971525 — intervention group
Group type: COMPARATOR
Intervention: Ovariectomy
Number of subjects: 57
Study 33063096 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led self-management and self-assessment program including educational video and home-based exercises, with monthly reporting of ASDAS/BASDAI scores.
Number of subjects: 502
Study 33063096 — intervention group
Group type: COMPARATOR
Intervention: Comorbidities assessment (control group).
Number of subjects: 502
Study 32143725 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM + real tDCS
Number of subjects: 30
Study 32143725 — intervention group
Group type: COMPARATOR
Intervention: ABM + sham tDCS
Number of subjects: 30
Study 33726315 — intervention group
Group type: EXPERIMENTAL
Intervention: Raman-based device for generating laser pulses with quantum-randomized polarizations
Number of subjects: 0
Study 32073608 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie breakfast (11% of daily kilocalorie requirement)
Number of subjects: 16
Study 32073608 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie dinner (69% of daily kilocalorie requirement)
Number of subjects: 16
Study 32073608 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast (low-calorie)
Number of subjects: 16
Study 32073608 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinner (high-calorie)
Number of subjects: 16
Study 33191871 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body intervention
Number of subjects: 51
Study 33191871 — intervention group
Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 51
Study 36085410 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoRings assisted colonoscopy (ER)
Number of subjects: 556
Study 36085410 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy (SC)
Number of subjects: 556
Study 34406315 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% NaOCI solution
Number of subjects: 114
Study 34406315 — intervention group
Group type: COMPARATOR
Intervention: 5.25% NaOCI gel
Number of subjects: 114
Study 36404630 — intervention group
Group type: EXPERIMENTAL
Intervention: RoFA mastectomy
Number of subjects: 100
Study 36404630 — intervention group
Group type: COMPARATOR
Intervention: Standard mastectomy
Number of subjects: 100
Study 32419594 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-mg intramuscular injections of a non-viral DNA plasmid
Number of subjects: 109
Study 32419594 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-mg intramuscular injections of a non-viral DNA plasmid
Number of subjects: 109
Study 32419594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 35751777 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) solid formulation, 200 mcg orally administered at 08:00 h
Number of subjects: 29
Study 35751777 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) liquid formulation, 200 mcg orally administered at 08:00 h
Number of subjects: 29
Study 33539945 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib plus nab-paclitaxel/gemcitabine
Number of subjects: 424
Study 33539945 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus nab-paclitaxel/gemcitabine
Number of subjects: 424
Study 32659160 — intervention group
Group type: EXPERIMENTAL
Intervention: Matching Adjusted Indirect Comparison (MAIC)
Number of subjects: 0
Study 32659160 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucher
Number of subjects: 0
Study 32659160 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated Treatment Comparison (STC)
Number of subjects: 0
Study 32659160 — intervention group
Group type: EXPERIMENTAL
Intervention: MAIC and STC adjusted for confounders
Number of subjects: 0
Study 36305113 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG-guided positioning
Number of subjects: 120
Study 36305113 — intervention group
Group type: COMPARATOR
Intervention: Body surface measurement and postoperative chest X-ray localization (Control)
Number of subjects: 120
Study 33890449 — intervention group
Group type: EXPERIMENTAL
Intervention: Costoclavicular block (CC)
Number of subjects: 80
Study 33890449 — intervention group
Group type: COMPARATOR
Intervention: Lateral sagittal infraclavicular block (LS)
Number of subjects: 80
Study 35761262 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐HIIT (supervised)
Number of subjects: 30
Study 35761262 — intervention group
Group type: EXPERIMENTAL
Intervention: H‐HIIT (unsupervised)
Number of subjects: 30
Study 35761262 — intervention group
Group type: COMPARATOR
Intervention: CON (no intervention)
Number of subjects: 30
Study 33085801 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored pharmacist-led intervention based on adherence barriers (forgetfulness, lack of knowledge, lack of motivation, other drug-related problems)
Number of subjects: 113
Study 33085801 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 113
Study 34705785 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific implants
Number of subjects: 64
Study 34705785 — intervention group
Group type: COMPARATOR
Intervention: CAD/CAM surgical splints
Number of subjects: 64
Study 32408551 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (69 families)
Number of subjects: 159
Study 32408551 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced control group (20 families)
Number of subjects: 159
Study 32408551 — intervention group
Group type: COMPARATOR
Intervention: Regular control group (70 families)
Number of subjects: 159
Study 36239907 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based resistance and aerobic exercise (EX) for 12 weeks
Number of subjects: 106
Study 36239907 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based resistance and aerobic exercise (EX)
Number of subjects: 106
Study 36239907 — intervention group
Group type: COMPARATOR
Intervention: Usual care/control (CON)
Number of subjects: 106
Study 33346683 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (25 nmol/L)
Number of subjects: 60
Study 32087691 — intervention group
Group type: EXPERIMENTAL
Intervention: FSRT (Fractionated Stereotactic Radiotherapy)
Number of subjects: 0
Study 36036889 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic APRs
Number of subjects: 347
Study 36036889 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic APRs
Number of subjects: 347
Study 33794498 — intervention group
Group type: EXPERIMENTAL
Intervention: Strip craniectomy (126 patients)
Number of subjects: 205
Study 33794498 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial vault remodeling (79 patients)
Number of subjects: 205
Study 33794498 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial vault remodeling with tranexamic acid
Number of subjects: 205
Study 33794498 — intervention group
Group type: COMPARATOR
Intervention: Cranial vault remodeling without tranexamic acid
Number of subjects: 205
Study 33794498 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall complication rates
Number of subjects: 205
Study 32196793 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH dietary pattern
Number of subjects: 511
Study 35476143 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 300 mg subcutaneously every 4 weeks
Number of subjects: 343
Study 35476143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343